REGN
Ticker
Regeneron
Company
Biopharma
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
21.0%-2.9%209.2%52.7%34.0%45.5%18.4%20.8%14.3%17.2%8.1%89.1%-24.3%7.8%8.3% 2.9%
Revenue Growth QoQ
Gross Margin
99.6%99.5%99.1%93.8%92.6%92.7%90.4%93.8%93.2%93.5%90.1%86.8%84.8%87.2%86.2%86.1% 85.4%
EBITDA Margin
-15.8%-16.9%-39.0%35.9%38.1%31.1%32.3%29.5%37.9%40.0%30.8%44.9%57.4%41.7%34.1%31.5% 29.6%
Operating Margin
-19.5%-21.2%-46.0%33.2%36.1%29.2%30.5%27.4%35.4%37.8%28.1%42.1%55.7%38.9%30.9%28.1% 25.9%
Profit Margin
-17.9%-22.8%-49.7%54.4%20.2%12.0%15.5%18.4%20.4%36.4%26.9%41.3%50.2%35.6%30.1%31.1% 32.1%
FCF / EBITDA
283.3%0.6%114.3%-25.1%53.3%47.8%49.2%67.0%46.5%67.5%82.7%52.6%70.7%87.1%86.7%81.9% 100.2%